Nextleaf Options, a major cannabis extraction technologies organization, has announced these days that it has added Dr. Sherry Boodram, former Senior Regulatory Compliance Officer with Wellness Canada, to its Board of Directors, successful right away.
Dr. Sherry Boodram worked for the Canadian federal government for quite a few years and was accountable for licensing application critiques and on-web page facility inspections of Canadian cannabis business facilities.
Dr. Boodram also supplied field level input through the drafting of the present Canadian cannabis regulations.
“Being a organization with values I can stand behind, I’m really excited to serve alongside Nextleaf’s current Board members and with their talented executive group,” stated Dr. Sherry Boodram. “Moreover, I appear forward to maximizing the exclusive know-how and expertise I gained though at Wellness Canada’s Healthcare Cannabis Plan, and in the cannabis business as a complete, to give knowledge in help of Nextleaf’s ongoing commitment to regulatory compliance, superior governance, and extended-term development as a leader in cannabis extraction technologies.”
Dr. Boodram holds a Ph.D. in Chemistry from York University, a B.Sc. (Hon) from the University of Toronto, and a Graduate Certificate with Honours in Pharmaceutical Regulatory Affairs and Top quality Operations from Seneca College. Dr. Boodram is also a member of the Canadian Association of Pros in Regulatory Affairs (CAPRA).
At the moment, Dr. Boodram is the co-founder and CEO of CannDelta Inc. (“CannDelta”) – a regulatory and scientific cannabis consulting organization primarily based out of Toronto, Canada – exactly where she delivers regulatory knowledge and develops techniques to make sure regulatory compliance inside Canada’s current legal cannabis framework.
“The critical regulatory infractions by quite a few huge Canadian licensed cannabis producers, along with an expanded scope of cannabis goods by means of legalization two., reinforces the important function that compliance oversight plays in developing a cannabis organization all stakeholders can be proud of,” stated Paul Pedersen, co-founder and CEO of Nextleaf Options. “Sherry is amongst the most credible and certified cannabis regulatory authorities in Canada, and we think her background, insights, and business expertise will add tremendous worth to our Board.”
About Nextleaf Options
Nextleaf Options Ltd. (“OILS”) is creating disruptive intellectual house for industrial-scale extraction, purification, and formulation of cannabinoids. OILS owns a portfolio of eight (eight) issued and 35 pending patents pertaining to the production of higher-purity, cannabinoid-wealthy distillate, the important ingredient applied in the manufacturing of standardized THC and CBD infused goods. When cannabis concentrates and edibles turn out to be legal across Canada, OILS plans to commercialize its intellectual house portfolio by means of IP licensing, B2B processing solutions, and the provide of THC and CBD oils and concentrates to certified Canadian and international partners.
Nextleaf Options trades as OILS on the Canadian Securities Exchange (CSE: OILS), OILFF on the OTCQB Marketplace in the United States (OTCQB: OILFF) and L0MA on the Frankfurt Stock Exchange (FSE: L0MA).
For much more info pay a visit to www.nextleafsolutions.com or adhere to OILS across social media platforms: Twitter, LinkedIn, Facebook, and Instagram.